TrialDrug design, development and therapy2023

Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants.

Tommy Tsang Cheung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.